Publisert 08.10.2013

Henrik Lund CEO

Henrik Lund MD, PhD appointed CEO of Regenics AS

Henrik Lund MD, PhD former CEO of Bionor ASA and DiaGenic ASA and Chairman of the Board of Oslo Cancer Cluster appointed CEO of Regenics AS.

Chairman Board of Directors RegenicsAS Tore Heldrup Rasmussen says: "It a pleasure to welcome Henrik Lund to lead Regenics in commercialisation phase of the companys exciting technology. Henrik brings a wealth of Life Science experience to us and I look forward to the next milestones"



Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.